Share this page Oxford PharmaGenesis at the Virtual 17th Annual Meeting of ISMPP Company overview video ISMPP is a fantastic opportunity to share best practice and connect with people who share our vision for what medical publications and communications can achieve. Presentations April 12, 2021, 12:00 PM – 1:00 PM – Tim Koder Tim Koder […]
Congrats winners of the 2021 @PMSociety Awards! We’re proud to have been shortlisted for @triMSonline, our virtual event series for the latest research in the field of #MultipleSclerosis. Thank you to @GavinGiovannoni and the Steering Committee who have worked on this initiative. https://t.co/LlbRuzog1x
JOB ALERT! Are you a #SeniorMedicalWriter with a passion for #RealWorldEvidence? If you enjoy leading projects in a fast-paced environment, this could be the role for you! Get in touch with us at firstname.lastname@example.org. #OxPharmCareers #MedComms https://t.co/f6A75XflpG https://t.co/9foAAY6K6W
Over the past year, feeling connected and supported has been more important than ever. @rarediseaseday is taking place this Sunday, 28 February. How are you showing support and solidarity with the rare disease community? #rareisMANY #rareisSTRONG #rareisPROUD #showushowRAREyouare https://t.co/RZ1IHslJu1
Putting the #PatientVoice at the forefront: read the plain language summary of publication #PLSP of the ARAMIS #ClinicalTrial in @fsgfon last week, co-authored by a trial participant and @prostateca, produced in partnership with @BayerPharma and @CISCRP https://t.co/5y86cMyXFS https://t.co/UUB3gBUhCJ
Open access and well-planned digital enhancements improve article discoverability and reader engagement, according to data from @SpringerHealth. Read about our research collaboration with @IpsenGroup, @SpringerHealth and @OxPharmaGenesis here https://t.co/4vumYQ8s6E #ISMPPEU2021 https://t.co/0z2hNFz5Mm
We’re proud to sponsor @CISCRP’s Clinical Trials Supplement in @USATODAY last month. “Pharmaceutical companies can take an important first step by informing healthcare providers about new clinical trial opportunities in underserved communities.” #Diversity https://t.co/lSjM1ZSi1N https://t.co/h08T9plRw4
12th April 2021
Virtual 17th Annual Meeting of ISMPP
Oxford PharmaGenesis is sponsoring this year's meeting of International Society for Medical Publication Professionals (ISMPP). We're taking part in discussions and debates on evolving issues for HealthScience such as Open Access, preprint, and Artificial Intelligence.
Last week marked the fourth Informatics Summit from the American Medical Informatics Association (AMIA). The meeting provided a fantastic opportunity for members of our Informatics and Data Science practice to stay up to date with the latest developments in the fields of artificial intelligence (AI), natural language processing and machine learning in the context of […]
Oxford PharmaGenesis and the US Friends of the National Library of Medicine: building global networks together
The Friends of the US National Library of Medicine has elected Chris Winchester, CEO of Oxford PharmaGenesis, to its Board of Directors in recognition of the growing collaboration between the two organizations. The move bodes well for the disclosure and dissemination of medical evidence from the pharmaceutical industry and beyond.
For the fourth year in a row, Oxford PharmaGenesis has been listed in the Alantra Pharma Fast 50 as one of the UK’s fastest-growing, privately owned pharmaceutical businesses.
Today I’m attending the online Women in Data Science Worldwide Conference, along with tens of thousands of professionals, speakers, ambassadors and thought leaders reports Hollie Rawlings (Data Analyst – Informatics and Data Science).
With the challenges presented over the past year, keeping in touch has been more important than ever. The COVID-19 pandemic has affected us all in different ways, and a short conversation with a colleague, friend or family member about mental health has the power to make a big difference.